| Poster Session: Allied Health |
| P1.01 |
Optimizing lung function during donor management through a multidisciplinary approach Elizabeth Shipman, United States |
| P1.02 |
Training and Social Awareness targeted for Allied Health professionals for Increasing Organ Donation in The European Union and neighboring Countries: EUDONORGAN Carmen Blanco, Spain |
| P1.03 |
Knowledge exchange program to increase the organ donation rates in Saudi Arabia Marti Manyalich, Spain |
| P1.04 |
Biovigilance - Implementation of a tool for notification of adverse events in cells, organs and tissues in a country in South America. Bartira B De Aguiar Roza A.R, Brazil |
| P1.05 |
Gender and transplantation. The impact of the social role of gender and its implications in the process of health-illness and care Graciela V. Gambina, Argentina |
| P1.06 |
Exploration of the influencing factors of the self-management in renal transplant recipients based on the health promotion model Hongxia Liu, People's Republic of China |
| P1.07 |
A new intervention to increase medication adherence in kidney transplant recipients: investigation of effect of SystemCHANGE intervention Yaprak Sarıgöl Ordin, Turkey |
| Poster Session: Basic and Translational Science |
| P2.01 |
IL-33/ST2 signaling pathway: preliminary study to assess its role in
chronic rejection after liver transplant
Maria Virginia Gentilini, Argentina |
| P2.02 |
Save the Environment: Liver Transplantation Restores a Circulating Environment that Supports Healthy Platelet Aggregation within Two Hours of Reperfusion Hillary Braun, United States |
| P2.03 |
Dynamic kidney rejection risk prediction using serial donor derived cell free DNA John Friedewald, United States |
| P2.04 |
Polymorphisms rs1800469, rs1800471 of the TGFB1 gene detected in patients with chronic heart failure who waiting cardiac transplantation Olga Gichkun, Russian Federation |
| P2.05 |
Influence of adding calcium channel blocker Verapamil during perfusion for functioning transplanted kidney within 36 months after transplantation (mid term results) Maciej Nowacki, Poland |
| P2.06 |
A survey of transplant recipient attitudes regarding contraception and pregnancy Deirdre Sawinski, United States |
| P2.07 |
Asxl1 may promote the differentiation and function of Th17 cells Puxun Tian, People's Republic of China |
| P2.08 |
Evaluation and maintenance of donor liver quality in rats from donated after cardiac death by hypothermic oxygenated machine perfusion and cold storage Fu Zhen, People's Republic of China |
| P2.11 |
Distinct global DNA methylation and NF-κB expression profile of preimplantation biopsies from ideal and non-ideal kidneys Mario Abbud-Filho Sr., Brazil |
| P2.13 |
Immunosuppression monotherapy does not protect donor leukocytes from depletion post MHC-mismatched kidney transplantation in mice. Sarah Dart, Australia |
| P2.14 |
Accelerating the differentiation of Neonatal porcine pancreatic cell clusters into beta cells in alginate-microcapsules. Heon-Seok Park, Korea |
| P2.15 |
A positive b2 microglobulin trend immediately after transplant identify worse outcomes in patients with delayed graft function Angelica Perez-Gutierrez, United States |
| P2.17 |
Retrograde reperfusion of the renal graft in adult recipient to reduce ischemia-reperfusion injury Myltykbay Rysmakhanov, Kazakhstan |
| P2.18 |
Local immune cells' phenotype after corneal graft rejection Justyna Sakowska, Poland |
| P2.19 |
Role of the intestinal microbiota in the course of chronic liver disease before and after liver transplantation results of a pilot study Umid Ravshanovich Salimov, Belarus |
| P2.20 |
Angiogenesis promoting effects of human amnion membrane in ischemia-impaired wound in a rat model Kazuaki Tokodai, Japan |
| P2.21 |
Protection of normal metabolic function of healthy pig livers following prolonged normothermic ex-situ perfusion Jordi Vengohechea Llorens, Spain |
| Poster Session: Bone Marrow |
| P3.01 |
Similar graft-versus-host disease (GVHD) incidence among unrelated and identical sibling donor transplantation with the use of anti-thymocyte globulin (ATG) Agustina Cia, Argentina |
| P3.02 |
Assessment of chimerism testing by next generation sequencing Mohamed Elrefaei, United States |
| P3.03 |
Allogeneic hematopoietic stem cells transplantation (AHSCT). Is still the sibling donor the best option? One single center experience Nicolas Fernandez Escobar Sr., Argentina |
| P3.04 |
Apraglutide Treatment Reduces Chemotherapy-induced Gastrointestinal (GI) Damage in Mice and Preserves Cellular Integrity Violetta Dimitriadou, Switzerland |
| P3.06 |
Apraglutide Does Not Impact Anti-tumor and Immunosuppressive Efficacy of Conditioning Chemotherapy in Mice Violetta Dimitriadou, Switzerland |
| P3.07 |
Treatment with Apraglutide Preserves the Global Homeostatic Environment of Intestinal Microbiota During Chemotherapy in Mice Violetta Dimitriadou, Switzerland |
| Poster Session: Critical Care and Anesthesia |
| P4.01 |
Searching new donation scenarios: potencial receptors "on the other side of the mirror" Paula Rivera Sánchez, Spain |
| P4.02 |
Performance of the Hypotension Prediction Index in living donor liver transplant recipients: a prospective observational study Seong Mi Yang, Korea |
| P4.03 |
Anesthetic management of a glycogen storage disease type 1a with air embolism during liver transplantation: a case report Emre Kandemir, Turkey |
| Poster Session: Education |
| P5.01 |
Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD) Chloë Ballesté, Spain |
| P5.02 |
Impacts on NHS renal transplant educational service delivery during the covid-19 global pandemic John Black, United Kingdom |
| P5.03 |
Teaching the new medical specialties: Transplant, the challenge of accompanying scientific progress from education. Maria del Carmen Bacque, Argentina |
| P5.04 |
Knowledge about donation and transplantation in the health team Maria del Carmen Bacque, Argentina |
| P5.05 |
Development of a multidisciplinary protocol for thoracic organ donation process Luiz Gustavo Torres Dias da Cruz, Brazil |
| P5.06 |
Health Professional Education Battsetseg Gonchigjav, Mongolia |
| P5.10 |
Cognitive profile and educational trajectory in adolescents and young adults with liver transplants at the Garrahan pediatrics hospital Lucia Bourdieu Yrujo, Argentina |
| P5.11 |
Education in the donation-transplant process in undergraduate medical training Marisa M. Cobos, Argentina |
| P5.12 |
Education of medical students on organ donation and transplantation Viktor Denisov, Ukraine |
| P5.13 |
Developing a standardized education program on deceased organ donation for pre-medical students Hee Jung Jeon, Korea |
| P5.14 |
Quality appraisal of evidence-based guidelines for the health education of solid organ transplantation Jing Sun, People's Republic of China |
| P5.15 |
Build-up on school education program to nurture the value of sharing and deceased organ donation for youth in Korea Jieun Oh, Korea |
| P5.16 |
Learning from the learning curve: the personal database of an entry-level transplant surgeon as a tool to improve outcomes
Alex Zendel, United States |
| Poster Session: Ethics and Transplantation |
| P6.01 |
Actuarial Perspective on the Immunosuppressive Medication Costs and Coverage for Transplant Recipients in the Argentine´s Public System: 2009-2021 Ignacio Drake, Argentina |
| P6.02 |
Provisional and promising bioethical conclusions on uterine transplantation Elian Pregno, Argentina |
| P6.03 |
Traumatic events and treatment non-adherence: a potential association? Daniel Osvaldo O Merino, Argentina |
| P6.04 |
Xenotransplantation and Bioethics Roberto Cambariere, Argentina |
| P6.05 |
Depression and suicide in end stage kidney disease (on dialysis and kidney transplant recipients): A national-wide population study. Jun Young Lee, Korea |
| P6.06 |
The monetary cost of delays in kidney transplantation in a public health facility in a developing country:Kenyan experience. John Ngigi, Kenya |
| P6.07 |
Risk factors for trauma death among transplant recipients Alejandro C Chiodo Ortiz, United States |
| P6.08 |
Questions about xenotransplantation in ethical and religious literature Boris I Yaremin, Russian Federation |
| P6.09 |
Extended Criteria Donor, Cold Ischemia Time and Delayed Graft Functions; common ingredients for an expensive recipe. Mohamed H Zahran, Egypt |
| Poster Session: Intestinal Transplantation |
| P7.01 |
Selecting candidates for multi-visceral transplantation in neuroendocrine tumors (NET) of the gastrointestinal tract; A review of two cases Peyman Arasteh, Iran (Islamic Republic of) |
| P7.04 |
A case of multivisceral transplantation in a patient with diffuse portal thrombosis, budd-chiari syndrome, previous portal-ivc shunt thrombosis and dalteparin allergy Carmelo Loinaz, Spain |
| P7.05 |
Current challenges to starting an intestinal transplant program in the world today: Perspectives from emerging economy Hamed Nikoupour, Iran (Islamic Republic of) |
| P7.06 |
Endovascular thrombectomy in a chronic upper cava syndrome due to long term home parenteral nutrition. New hope to extend life support. Camila Caceres, Argentina |
| P7.07 |
Thyroid infection caused by invasive aspergillosis in solid organ transplantation: a case report Hector Solar, Argentina |
| P7.08 |
Intestinal transplantation in a country without home parenteral nutrition; the largest report from the middle east
Pooya Vatankhah, Iran (Islamic Republic of) |
| P7.09 |
Population Model Confirms Predictable Pharmacokinetic (PK) and Pharmacodynamic (PD) Profile for Apraglutide: Data from Two Randomized Phase 1 Studies Gerard Greig, Switzerland |
| P7.10 |
A Phase 1, Open-Label Evaluation of the Pharmacokinetics and Safety of a Single Dose of Apraglutide in Subjects with Normal and Impaired Renal Function Gerard Greig, Switzerland |
| Poster Session: Kidney |
| P8.001 |
Robotic-assisted living donor nephrectomy: high technology incorporated for patient benefit Phillipe Abreu, United States |
| P8.002 |
Cholelithiasis: Should we be more Aggressive in Transplant Patients? Phillipe Abreu, United States |
| P8.003 |
Post-transplant diabetes de NOVO (NODAT) in a Paraguayan kidney transplant population: prevalence and risk factors Juan D Acosta Sr., Paraguay |
| P8.004 |
Kidney graft surveillance biopsies, histological findings and safety of the procedure Maria Nieves I Aran, Argentina |
| P8.005 |
Collapsing glomerulopathy recurrence in a kidney transplant patient Valeria Gabriela Alberton, Argentina |
| P8.005a (331.6 in the Journal) |
Impact of Left Ventricular Ejection Fraction and Previous Cardiac Revascularization on Kidney Transplant Recipient Outcomes
Dominic Amara, United States |
| P8.006 |
Urinary tract infections in kidney transplant. Treatment duration and recurrences : A Multicenter study in Argentina Laura Barcan, Argentina |
| P8.007 |
Single Nuclei RNA-sequencing Unravels Complex Renal and Immune Cells Signaling Driving Fibrosis in Kidney Allografts Jennifer McDaniels, United States |
| P8.008 |
Single Nuclei Profiling of Focal and Segmental Glomerulosclerosis from Human Allografts Jennifer McDaniels, United States |
| P8.009 |
The association between atherosclerosis and intrarenal resistance index in kidney transplant recipients Niels T. Bloemendal, Netherlands |
| P8.010 |
The association of Torque Teno viral (TTV) load with acute rejection and viral infections in the first-year post renal transplantation Natalia Boccia, Argentina |
| P8.010a (342.10 in the Journal) |
IgA Nephropathy and Kidney Transplantation According to the Oxford Classification Marcos Sousa, Brazil |
| P8.011 |
Urological complications and urinary tract infections depending on urinary outflow in pediatric patients after kidney transplantation Dorota Broniszczak-Czyszek, Poland |
| P8.012 |
The impact of A Positive B-cell Flow Crossmatch in Living Donor Renal Transplant Recipients Jorge M Chancay, United States |
| P8.013 |
Associations of circulating MicroRNAs (miR-21-5p, miR-20a-5p) and chronic allograft nephropathy in renal transplant recipients Cheng-Hsu Chen, Taiwan |
| P8.015 |
Prevalence and risk factors associated with persistent hyperparathyroidism in kidney transplant recipients Sofia Conci, Argentina |
| P8.016 |
Gram negative blood stream infection in renal transplant recipients: Risk factors and outcome from a transplant center in Pakistan Sunil Kumar Dodani, Pakistan |
| P8.017 |
Post renal transplant malignancy: single center experience Elizete EK Keitel MD, Brazil |
| P8.018 |
Human leukocyte antigen tissue typing in a Guatemalan transplant center Karla O. Escobar, Guatemala |
| P8.019 |
Improving Access to Kidney Transplantation: Waitlisting and Kidney Transplantation in Southeastern Brazil Gustavo Ferreira, Brazil |
| P8.020 |
Incidence and Correlates of Testicular Pain After Kidney Donation Nisarg V Gandhi, United States |
| P8.021 |
Study the effect of sodium-glucose cotransporter-2 inhibition versus dipeptidyl peptidase-4 inhibition in diabetic kidney transplant recipients Osama Ashry Gheith, Egypt |
| P8.022 |
Structured diabetes education: significance among kidney transplants recipients with post-transplant diabetes Osama Ashry Gheith, Egypt |
| P8.023 |
Acute kidney injury among COVID-19 positive patients is associated with higher mortality: single center experience Osama Ashry Gheith, Egypt |
| P8.024 |
Evaluation of function of angiopoietins and ANIOPOIETIN likes in post-transplantation diabetes mellitus (PTDM) in Kuwaiti kidney transplanted patients Osama Ashry Gheith, Egypt |
| P8.026 |
Contrast-induced nephropathy in kidney transplant recipients: a single-center experience Osama Ashry Gheith, Egypt |
| P8.027 |
Idiopathic polymyositis in renal transplant recipient: case report and review of literature Osama Ashry Gheith, Egypt |
| P8.028 |
Impact of autophagy on the development of senescence in protocol biopsies in kidney transplant patients Maria C. Giordani, Argentina |
| P8.029 |
Mini-flank donor nephrectomy incision: a single centre experience from Nigeria Martin C. Igbokwe, Nigeria |
| P8.031 |
Outcome of simultaneous pancreas kidney transplantation a single center experience George Kurian, India |
| P8.032 |
Post-transplant malignancy amongst kidney transplant recipients: A Single Centre 20-year Experience and literature review George Kurian, India |
| P8.033 |
Teriparatide in kidney transplant patients with bisphosphonate-resistent osteoporosis Luis Roberto Leon, Argentina |
| P8.034 |
Single Port Robotic versus Open Kidney Transplantation: A Comparison of Outcomes Yi-Chia Lin, United States |
| P8.035 |
Early Recovery After Surgery Program in Kidney Transplantation Patients: Comparison of Clinical Outcomes with Conventional Care Program Yi-Chia Lin, United States |
| P8.036 |
Late humoral rejection: will temporality be enough to determine the therapeutic attitude? Luis Eduardo Morales Buenrostro, Mexico |
| P8.037 |
Changes in Body Composition after renal transplant in Children Mara Medeiros, Mexico |
| P8.038 |
Prevalence of genetic mutations associated with kidney disorders in renal transplant recipients – single centre experience Ankur Mittal, India |
| P8.039 |
Allele, genotype and haplotype frequencies of the HLA system in the province of Neuquén, Argentina. Mariano Javier Navello, Argentina |
| P8.040 |
Vascular Surgeon in transplantation team, is there a room for such specialist? Maciej Nowacki, Poland |
| P8.041 |
The gift of life and nonadherence in renal transplant recipients Karly M Nygaard-Petersen, Canada |
| P8.042 |
Non-melanoma skin cancer with an aggressive course in kidney transplant patients treated with rapamycin. Ana K Ochoa, Argentina |
| P8.043 |
Molluscum contagiosums as a cutaneous marker of immune reconstitution syndrome in a renal transplant patient Ana K Ochoa, Argentina |
| P8.044 |
Factors contributing to acute rejection within one year of kidney transplantation with a perspective of Tacrolimus trough level; a nationwide cohort study Cheol Woong Jung, Korea |
| P8.045 |
Modern Medicine Needs Modern Technology Tools Zohreh S Soltani, United States |
| P8.046 |
Laparoscopic kidney transplantation: a minimally invasive alternative for our country Francisco J Osella, Argentina |
| P8.047 |
An Arrow For Two Targets: Kidney Donation In Unilateral Renal Artery Stenosis Mayur Patil, India |
| P8.048 |
Organ preserving cardiopulmonary resuscitation in a resource limited country to increase donor pool Mayur Patil, India |
| P8.049 |
Treatment of chronic active antibody-mediated kidney transplant rejection with intravenous immunoglobulin Nadzeya Rapetskaya, Belarus |
| P8.050 |
Pediatric donor transplants to adult recipients: follow-up and outcome Manuel Rengel, Spain |
| P8.051 |
Corticosteroids withdrawal in renal grafted patients: follow-up and outcome Manuel Rengel, Spain |
| P8.052 |
Long-term outcomes and predictors of graft function in living-donor preemptive kidney transplants. Lúcio Requião-Moura, Brazil |
| P8.053 |
Case report: nephrotic-range proteinuria in a deceased donor recipient with acute antibody mediated rejection and familiar FSGS Jose Otto Reusing Junior, Brazil |
| P8.054 |
Out of the box. Immunosuppressive therapy with four drugs as rescue therapy in kidney transplant recipients with chronic allograft rejection.
Wanda Rojas, Argentina |
| P8.055 |
Systemic heparinization in kidney donors during nephrectomy Leonardo R Romeo, Argentina |
| P8.056 |
Laparoscopic managment of ureteral stricture after kidney transplantation Leonardo R Romeo, Argentina |
| P8.057 |
Cannabidiol (CBD) oil and tacrolimus – The unexpected high in renal transplant recipients – Case series and review Mrinalini Sarkar, United States |
| P8.058 |
Second and Third Renal Transplant During Covid 19 – A Single Center Experience in India. Kity Sarkar, India |
| P8.059 |
Kidney transplant outcome according to pre-transplant dialysis modality Ruben O. Schiavelli, Argentina |
| P8.060 |
Renal transplantation in the elderly. Are they all the same? A multicenter, comorbidity based study Gervasio Soler Pujol, Argentina |
| P8.061 |
Recurrence of Membranoproliferative Glomerulonephritis After Kidney Transplantation: Risk Factors and Impact on Graft Function and Survival Marcos Sousa, Brazil |
| P8.062 |
Prevalence of hyperkalemia (HK) among stable kidney transplant patients Marcelo F Taylor, Argentina |
| P8.063 |
Single-cell analysis reveals immune landscape in kidney transplant recipients with antibody-mediated rejection Puxun Tian, People's Republic of China |
| P8.064 |
Development and validation of a nomogram for remnant kidney function after living-donor donation Puxun Tian, People's Republic of China |
| P8.065 |
Covid-19 and pediatric kidney transplantation: Iberoamerican multicentric study Sebastián Tobia, Argentina |
| P8.066 |
Effect of renal pre-transplant desensitization on renal graft function and survival at 1 and 3 years Lionel Cristian Arispe Vargas Sr., Mexico |
| P8.069 |
Delayed graft function: a single center experience Carlos J Cobeñas, Argentina |
| P8.069a (242.12 in Journal) |
The outcome of the inferior epigastric artery as a donor vessel for managing accessory renal arteries in renal transplantation: a systematic review and meta-analysis Animesh Singla, Australia |
| P8.070 |
A Case Report: HLA Antibodies in Temporal Relation to Vaccination in an End-Stage Renal Disease Pediatric Patient on the Renal Transplant Waiting List Nidia E. Gomez, Paraguay |
| P8.071 |
Outcomes In Kidney Transplant Recipients With Allograft Failure Who Return To Dialysis
Lauren Arena, Canada |
| P8.072 |
Sex differences in acute kidney injury following BD - an isolated rat organ perfusion model Roberto Armstrong Junior, Brazil |
| P8.073 (240.7 in Journal) |
Macrophages and different subtypes infiltrated in kidney allografts with antibody-mediated rejection Puxun Tian, People's Republic of China |
| P8.074 (342.5 in journal) |
Risk Stratification for Kidney Transplant Recipients: a Single-Center Study Puxun Tian, People's Republic of China |
| P8.075 |
Changes in the kidney allocation model in Uruguay - HLA compatibility vs. time on waiting list Adriana Tiscornia, Uruguay |
| P8.076 (240.11 in Journal) |
Effect of mycophenolic acid and tacrolimus on the incidence of infectious complications after kidney transplantation Matej Vnučák, Slovakia (Slovak Republic) |
| P8.078 |
Serial plasma exchange is a promising effective method in blood hemagglutinin level reduction Shaimaa Z Abdelmegied, Egypt |
| P8.079 |
Systematic review and meta-analysis on the effect of blood transfusions on kidney transplant outcomes: shining new light on an age-old debate Nauman N Ahmed, Australia |
| P8.080 |
Prevalence of new onset diabetes after transplantation in native Africans. Ihab A M Ahmed, Sudan |
| P8.081 |
Differential control of systolic and diastolic blood pressure in renal transplant recipients Nayef Mohammad Alawadh, Saudi Arabia |
| P8.082 |
Incidence and associated factors with uncontrolled hypertension at 12- months post-renal transplantation Nayef Mohammad Alawadh, Saudi Arabia |
| P8.084 |
Renal Transplantation And Statins Effects On Dyslipidemia In Renal Transplant Recipients Abdullah A Alghamdi, Saudi Arabia |
| P8.085 |
Outcomes of Post Kidney Transplant Lymphoproliferative Disorder (PTLD) Fatima AlKindi, United Arab Emirates |
| P8.087 |
Semaglutide May be Safe after Kidney Transplant Nizar Attallah, United Arab Emirates |
| P8.088 |
Mid term evolution of the glomerular filtration rate in living kidney donors Tatiana Baltesova, Slovakia (Slovak Republic) |
| P8.092 |
Conversion from MPA twice a day to MPA once a day following kidney and pancreas/kidney transplantation Diego Cantarovich, France |
| P8.093 |
ABO incompatible renal transplantation in Argentina: experience in a tertiary referral university hospital Carlos Raúl Chiurchiu, Argentina |
| P8.094 |
Assessment of urinary tract infections microbiologically in kidney transplant recipients Nuran Sari, Turkey |
| P8.095 |
Rasch Validation of the Psychosocial Assessment of Candidate Transplant Scale for Patients on Waitlist Deceased Donor Kidney Transplantation in South Korea Hye Jin Chong, Korea |
| P8.096 |
Adaptation Process after Kidney Transplantation in Korean Elderly recipients: A Qualitative Study Hye Jin Chong, Korea |
| P8.097 |
Patient experience of the kidney transplant waitlist: An Australian cohort study Nicole L De La Mata, Australia |
| P8.098 |
Surveying the quality of life and its dimensions among kidney recipient patients referred to the sina organ procurement unit In 2021 Sanaz Dehghani, Iran (Islamic Republic of) |
| P8.099 |
Post-operative myocardial infarction after renal transplant: setback or disaster? Joanne Devlin, United Kingdom |
| P8.100 |
Transplant in times of the beginning of SARS-coV2 pandemic, experience in reference center public hospital in Mexico Luis Garcia Sr., Mexico |
| P8.101 |
Is pregnancy possible in kidney transplant patients? Experience in a reference center in Mexico. Aldo Garcia C., Mexico |
| P8.102 |
Teratoma in transplanted patient, case report and review Aldo Garcia C., Mexico |
| P8.103 |
Main clinical outcomes in living-donor kidney transplantation: A Latin-American cohort. Fernando Giron, Colombia |
| P8.104 |
Main outcomes of pediatric living donor kidney transplantation: A Latin-American cohort. Fernando Giron, Colombia |
| P8.105 |
Risk factors for urologic complications after kidney transplantation and impact in graft survival Andrea García, Colombia |
| P8.106 |
Comparison of three glomerular filtration rate estimating equations with 24-hour urine creatinine clearance measurement in live kidney donors Andrea García, Colombia |
| P8.107 |
Predicting 5-year survival after kidney transplantation in Colombia Andrea García, Colombia |
| P8.109 |
Simultaneous vascular and antibody-mediated rejection (AMR) in pediatric patients caused poor prognosis in renal allograft Alev Ok Atılgan, Turkey |
| P8.111 |
Epstein-Barr virus-positive T-cell lymphoma characterized by intestinal involvement with multiple perforation in an adult renal allograft recipient: two case reports Pelin Borcek, Turkey |
| P8.112 |
Pregnancy outcomes in kidney transplant recipients and their newborns Burak Sayin, Turkey |
| P8.113 |
Starting a new life thanks to a successful kidney transplant after 30 years of hemodialysis: Case report Burak Sayin, Turkey |
| P8.115 |
Polyomavirus infection in the urine for follow-up of renal transplant patient: a single center study Ho Trung Hieu, Viet Nam |
| P8.118 |
Effect of Donor vs Recipient Delta of Age and BMI on Kidney Transplantation Outcome
Emanuele Federico Kauffmann, Italy |
| P8.119 |
Simultaneous Pancreas-Dual Kidney Transplantation: a case report Emanuele Federico Kauffmann, Italy |
| P8.120 |
Impact of desensitization in immunological low-risk patients in kidney transplantation
Youngmin Ko, Korea |
| P8.121 |
Inguinal herniation after kidney transplantation Takashi Kobayashi, Japan |
| P8.122 |
Tacrolimus dose reduction as an effective therapeutic approach to the patients with active BK virus replication and nephrotoxicity Karel Krejčí, Czech Republic |
| P8.123 |
A retrospective comparison of ABO incompatible with ABO compatible and Cadaveric renal transplant, single centre experience . Janmejay A Kunpara, India |
| P8.124 |
Recurrence of focal segmental glomerulosclerosis after kidney transplantation according to pre-transplant treatment Hye Eun Kwon, Korea |
| P8.125 |
Anti-thymocyte globulin versus basiliximab induction for kidney transplantation in elderly patients: Matched analysis with Korean multicentric registry Jun Young Lee, Korea |
| P8.126 |
Angiotomography in the vascular assessment of recipients before renal transplantation: a profile of excluded patients Marcos Sousa, Brazil |
| P8.127 |
Risk factors for chronic allograft rejection after kidney transplantation: a systematic review and meta-analysis Gede Wira Mahadita, Indonesia |
| P8.128 |
Results of a non-restrictive acceptability policy for kidney transplantation in patients with HLA sensitization Lucila Martin Rollan, Argentina |
| P8.129 |
Description of the process of inclusion and kidney transplantation waiting list - Uruguay Sebastián Marton, Uruguay |
| P8.130 |
Assessing Patient-Level Predictors of Obesity for Kidney Patients Referred for PreTransplant Evaluation Terri Menser, United States |
| P8.131 |
Kidney removal from the living donor-technique and evaluation: study on 256 samples
Karim Meskouri, Algeria |
| P8.132 |
Living kidney-donation: is the donator sheltered from cardiovascular risk factors? Malek Mojaat, Tunisia |
| P8.133 |
Metabolic outcomes still occur, but Kidney donation is obviously safe Malek Mojaat, Tunisia |
| P8.134 |
Advanced cancers treated with PD-L1 inhibitors and CTLA-4 antagonist in transplanted immunosuppressed patients: systematic review of graft outcome Marika Morabito, Italy |
| P8.135 |
Machine learning in kidney transplantation: a new possibility for the graft survival prediction Marika Morabito, Italy |
| P8.136 |
Treatment of calcifying uremic arteriopathy in a renal transplant service Liliana Miriam Obregon, Argentina |
| P8.137 |
Bladder evaluation in transplant patients : Are we overdoing it ? Sujata Kiran Patwardhan, India |
| P8.138 |
Kidney graft survival in pediatric patients at the UMAE Pediatric Hospital of CMNO Gabriela Esperanza Esperanza Pedroza Orozco, Mexico |
| P8.139 |
Progression of chronic kidney disease in pediatric patient with kidney transplantation
Laura K. Pineda, Argentina |
| P8.140 |
Pregnancy Outcomes After Renal Transplantation. Two-year follow-up Johanna Caldano, Argentina |
| P8.141 |
Prevalence and outcome of kidney transplant recipients infected with BK Polyoma virus at National Kidney and Transplant Institute from 2016 to 2021 Angelo R. Rocafort, Philippines |
| P8.142 |
Perturbations in podocyte transcriptome and biological pathways induced by injury caused by FSGS associated circulating factors Tara Sigdel, United States |
| P8.143 |
Assessment of renal allograft function via urine-based estimation of glomerular filtration rate Tara Sigdel, United States |
| P8.144 |
Regulatory T Cell Populations May Be Associated With Transplant Outcomes Ho Sik Shin, Korea |
| P8.145 |
Patient reported outcomes following renal transplantation: the future of holistic post-transplant care Harry VM Spiers, United Kingdom |
| P8.146 |
Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients: Risk Factors and Outcome Matthew Tavakol, United States |
| P8.147 |
Predictors of metabolic syndrome following one-year post kidney transplantation among Vietnamese patients Nguyen Thu Ha, Viet Nam |
| P8.148 |
HLA desensitization in kidney transplantation Aida Turganbekova, Kazakhstan |
| P8.149 |
Development of post-transplant malignancy in kidney transplant recipients Kalliopi Vallianou, Greece |
| P8.151 |
Serum Klotho and FGF-23 levels and their variability within two years after kidney transplantation Teresa Vazquez Sanchez, Spain |
| P8.152 |
Clinical characteristics and factors related to recurrent cytomegalovirus infection post-kidney transplant in adult patients at Cho Ray hospital Tho Ngoc Anh Vo, Viet Nam |
| P8.153 |
Confirmatory factor analysis of the Chinese version of self-management support scale for kidney transplant recipients Changyun Wei, People's Republic of China |
| P8.154 |
A nomogram for predicting BK virus activation in kidney transplantation recipients using clinical risk factors Cheng Yang, People's Republic of China |
| P8.155 |
Current trends in anemia treatment in kidney transplant recipients Anete Granovska, Latvia |
| P8.156 |
The unfavorable influence of oral health on pre-kidney-transplant patients' quality of life Paulo S da Silva Santos, Brazil |
| Poster Session: Liver |
| P9.01 |
Impact of the pandemic on liver transplantation and use of telemedicine – clinical hospital UNICAMP Ilka FSF Boin, Brazil |
| P9.02 |
Percutaneous transhepatic TIPS for Budd-Chiari syndrome as a bridge to liver transplantation Fatih Boyvat, Turkey |
| P9.03 |
Epidemiology of patients with Hepatocellular Carcinoma in a universitary hospital during a 12-year period: a cohort study Francisco Maria Calderon Novoa, Argentina |
| P9.04 |
Evaluation of Quality of Life in Adult Patients after One Year Liver Transplantation Jose Gabriel Cervantes, Argentina |
| P9.05 |
Biliary complications following liver transplantation: A 13-Years Single-center experience
Maria Florencia Fernandez, Argentina |
| P9.06 |
Liver transplantation for treatment of acute liver failure after COVID 19 infection and anatomopathological results Guilherme Ferrarini, Brazil |
| P9.07 |
Post Liver Transplantation Renal Impairment: Experience with the First 100 cases in a Single Center in Mongolia Angel Flores-Huidobro Martinez, United States |
| P9.08a (346.7 in Journal) |
Liver Biopsy in a clinic set up Ruby Ann Labayo Recaido, Saudi Arabia |
| P9.09 |
Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: experience of a high-volume center
Rodrigo A. Gasque MD, Argentina |
| P9.10 |
Mono-maintenance therapy with anti-ICAM-1 monoclonal antibody induced long-term liver allograft survival in nonhuman primates Dongkyu Han, Korea |
| P9.12 |
The impact of the multiple bile ducts on postoperative biliary complications in living donor liver transplantation; single center experience Doojin Kim, Korea |
| P9.13 |
Outcomes in pediatric recipients of living donor liver transplantation Ivone Malla, Argentina |
| P9.14 |
Massive blood transfusion: risk factors and consequences Alberto A Marcacuzco Quinto, Spain |
| P9.15 |
What about the heroes? Living donor liver outcomes, from a single Latin-American center experience between 2009-2022 Leonardo Montes Sr., Argentina |
| P9.16 |
Validating survival scores following liver re-transplantation, at a single center Leonardo Montes Sr., Argentina |
| P9.17 |
New index for prediction of massive blood transfusion Blanca Otero Torrón, Spain |
| P9.21 |
Future Liver Remnant Volume Ratio Less Than 30% Is Not A Contraindication To Living Donor Right Hepatectomy JOODONG KIM, Korea |
| P9.22 |
Surgical site infection in liver transplant patients: Evidence from real-world studies Md Azharuddin, India |
| P9.23 |
Single center study on liver transplantation since 1988: expected life expectancy and affecting factors Rengin Erdal, Turkey |
| P9.24 |
An alternative abdominal closure technique after pediatric liver transplant: Bogota-bag technique Emre Karakaya, Turkey |
| P9.25 |
Stereotactic ablative body radiotherapy as a bridge to liver transplantation for hepatocellular carcinoma: Başkent university experience Ebru H. Ayvazoglu Soy, Turkey |
| P9.27 |
Different severity and disparate clinical outcomes between EAD sub-criteria and proposal of a new EAD classification after liver transplantation Jinbo Huang, People's Republic of China |
| P9.28 |
Low intra-operative urine output is associated with the development of severe acute kidney injury and continuous renal replacement therapy requiring after liver transplantation Jinbo Huang, People's Republic of China |
| P9.29 |
Respiratory Syncytial Virus pneumonia in a LDLT recipient transplanted for COVID 19 precipitated ACLF: managed with Ribavirin and IvIg sorabh kapoor, India |
| P9.30 |
Salvaging small for size grafts with splenic artery embolization in living donor liver transplant: older liver may not recover sorabh kapoor, India |
| P9.31 |
Devising bile duct anastomosis to reduce biliary complications in living donor liver transplantation at our hospital Toshiaki Kashiwadate, Japan |
| P9.32 |
Excellent outcome quality is not dependent on a high caseload in liver transplantation Daniela Kniepeiss, Austria |
| P9.33 |
Prevention strategies against CMV-infection after liver transplantation Daniela Kniepeiss, Austria |
| P9.34 |
Application of mesenchymal stem cells for the treatment of liver graft dysfunction caused by chronic rejection. Case report.
Aliaksei Shcherba, Belarus |
| P9.35 |
Application of CRL-classification (J. Yan et al., 2020) principles for description of rare hepatic artery anomalies.
Aliaksei Shcherba, Belarus |
| P9.36 |
Impact and consequences of recipient Gastroduodenal Artery (GDA) ligation prior to Hepatic Artery (HA) anastomosis during Orthotopic Liver Transplantation (OLT) Aman Kumar, United States |
| P9.37 |
Liver transplantation for Abernathy malformation (congenital absence of portal vein). A case report Jayant Kumar, United States |
| P9.40 |
Liver transplantation for secondary hemophagocytic lymphohistiocytosis associated acute liver failure: a case report Jing-Yi Liu, People's Republic of China |
| P9.41 |
Outcomes of live donor liver transplantation in adult patients with HPS – 10-year experience from a single centre: A retrospective analysis Rohit Mehtani, India |
| P9.42 |
Ventral hernia repair following liver transplantation: Outcomes of repair techniques and risk factors for recurrence Megan Melland-Smith, Canada |
| P9.44 |
Single-cell RNA Transcriptomics Reveals Intrahepatic Macrophage Remodeling in Hepatitis B-Related Acute-on-Chronic Liver Failure Bo Peng, People's Republic of China |
| P9.45 |
Report of the first cases of hepatic SPLIT for liver transplantation in Peru Jose Rivera Romani, Peru |
| P9.46 |
Transition from pediatrics to adults: how adolescents with solid organ transplantation move to adult care in a general hospital Maria Camila Sanchez, Argentina |
| P9.47 |
FIPS score as a predictor of 30-day mortality after liver transplantation – a comparison with validated risk scores (SOFT and BAR) in a Brazilian cohort of patients. Fabio Silveira, Brazil |
| P9.48 |
A systematic review of the use of patient-reported outcome measures (PROMs) in adults undergoing liver transplantation Samira Elize Mariko van Knippenberg, Netherlands |
| P9.49 |
Efficacy analysis of liver transplantation and Vasomodulators therapy for portalpulmonary hypertension Li-Na Wu, People's Republic of China |
| P9.50 |
Novel MLTR classification of portal vein thrombosis for purposes of liver transplantation Boris I Yaremin, Russian Federation |
| P9.51 |
Single-cell RNA transcriptomics reveals dysfunction of hepatic lymphatic endothelial cells in Hepatitis B-Related Acute-on-Chronic Liver Failure Pengpeng Zhang, People's Republic of China |
| P9.52 |
Role Of Circulating Tumour Cells In The Management Of The Liver Transplant Patient With Hepatocellular Carcinoma Felipe Alconchel, Spain |
| P9.53 |
Clinical Relevance Of Pivka-ii After Liver Transplantation For Hepatocellular Carcinoma Felipe Alconchel, Spain |
| P9.54 |
Graft Versus Host Disease Following Liver Transplantation. A serious complication.
Carlos W. Florez Zorrilla, Mexico |
| P9.55 |
The role of interventional radiology in the management of early vascular complications after liver transplantation Fatih Boyvat, Turkey |
| Poster Session: Miscellaneous Topics |
| P10.01 |
How did the war affect organ transplantation in Syria? Bassam Saeed, Syrian Arab Republic |
| P10.02 |
Dapsone Induced Hemolytic Anemia In Solid Organ Transplant Recipients With Normal G6PD Activity Walaa Dabbas, United States |
| P10.03 |
Alternative surgical techniques for abdominal wall graft donation to guarantee abdominal wall closure in the donor. Clara Fernández, Spain |
| P10.04 (347.10 in the Journal) |
Worse Graft Outcome after Pregnancy in Female Transplant Recipients Cheng-Hsu Chen, Taiwan |
| Poster Session: Organ Donation and Procurement |
| P11.01 |
Increasing the consent for Brain death donor family members Altantulga Bayaraa, Mongolia |
| P11.02 |
Application of ex-vivo normothermic machine perfusion to assess renal allograft viability following renal vein thrombosis Ashish Sharma, India |
| P11.03 |
Access to kidney and liver transplantation in the adult and pediatric population: Interference of Argentine legislation Carolina Gabriela Genovese, Argentina |
| P11.04 |
Evolution and impact of regional investment projects on public offer of organ procurement and transplantation in Argentina: an analysis from 2008 to 2021 Adriana Procupet Blaustein, Argentina |
| P11.06 |
HTK vs WISCONSIN and Delayed Renal Graft Function José Emiliano Alfonso Sr., Argentina |
| P11.07 |
BMSCs combined with normothermic machine perfusion resuscitate aged donor liver with long warm ischemia time in rats Yiwen Guo, People's Republic of China |
| P11.44 (247.7 in Journal) |
Trends and Risk Factors for Mortality While Awaiting Heart Transplantation: a UNOS Registry Analysis Nicholas R Hess, United States |
| P11.08 |
International Registry in Organ Donation and Transplantation (IRODAT) – 2021 Worldwide data Marian Irazabal, Spain |
| P11.09 |
New technique for the extraction of abdominal wall grafts Iago Justo, Spain |
| P11.10 |
Changes of Brain Death Donors for recent 10 years in Korea (Based on Organ Transplantation Law) Mina Lee, Korea |
| P11.11 |
A new designed machine perfusion system to mimic the cardiac cycle's heart function for a better hepatic microcirculation perfusion Fan Lin, People's Republic of China |
| P11.12 |
Global and country-level growth in deceased organ donation over two decades Yosef Manla, United Arab Emirates |
| P11.13 |
Organization of Organ and Bone Marrow Donation and Transplantation in Poland Klaudia Nestorowicz-Kałużna, Poland |
| P11.14 |
The use of ex vivo normothermic perfusion to 'pause' cold ischaemic time to allow for third recipient to be selected and undergo kidney transplant Robert C Pearson, United Kingdom |
| P11.15 |
DONASUR: Descriptive analysis of 11 years of Argentina's participation Romina Perez Manelli, Argentina |
| P11.16 |
Quality monitoring indicators in the process of organ and tissue donation for transplantation: a scoping review preliminary results Rafael Rodrigo da Silva Pimentel, Brazil |
| P11.17 |
Sustaining life after brain death during pregnancy: a case report Marco Sacchi, Italy |
| P11.18 |
Allocating deceased donor using local vs imported renal allografts: logistics are more important than distance Reza F Saidi, United States |
| P11.19 |
System-Level Barriers to Living Donor Kidney Transplantation: A Cross-Sectional Survey Study of Health Professionals Shaifali Sandal, Canada |
| P11.20 |
Detailed analysis of autopsies on brain-dead organ donors Ki Dong Song, Korea |
| P11.21 |
Appointed donor responsible doctor and donor responsible nurse increase organ transplantation in Sweden Wenche Stribolt, Sweden |
| P11.24 |
The Korean experiences of re-use transplanted liver or kidney: case series Eun Jin Woo, Korea |
| P11.25 |
Why do not all living kidney donor candidates are accepted for donation? A pediatric center experience Ana B Calderón Alvarado, Mexico |
| P11.26 |
Serological profile of donors in Argentina Marisa M. Cobos, Argentina |
| P11.27 |
Changes in markers of coagulation and fibrinolysis offer insights into pathophysiological aspects of preservation injury during normothermic liver perfusion Jule Dingfelder, Austria |
| P11.28 |
Effect of temporal Trends in Donor Demographics on Perioperative Outcomes in Robotic Living Donor Nephrectomy Arshad B Khan, United States |
| P11.29 |
Improving Tissue Donation referral rates from the Emergency Department - a QI project Susan Macmillan, United Kingdom |
| P11.30 |
Influence of basic cardiopulmonary reanimation on uncontrolled donors after cardiac death Alfonso Mateos-Rodriguez, Spain |
| P11.31 |
Gendering Organ Donation: Experiences of living women organ donors in India Nishtha Mishra, India |
| P11.32 |
Brain death in Uruguay. 19 years of experience Ana Castro, Uruguay |
| P11.33 |
Donation and transplantation indicators in the pre and post pandemic stage. Organ Use Rate Agustin M Carambula Simon, Uruguay |
| P11.34 |
Tissue donation indicators in Latin American and European countries. A way to measure the efficiency of the organizational system Raul Mizraji, Uruguay |
| P11.35 |
Using Emotional Text Mining to explore the cultural representation of organ donation in the Spanish and Italian culture Silvia Monaco, Italy |
| P11.36 |
Indocyanine Green (ICG) Angiography for Assessing Microcirculation Patency Improvement after Hypothermic Machine Perfusion (HMP) Re-Conditioning: A Pilot Study Marika Morabito, Italy |
| P11.37 |
A new successful training method for brain death family approach Katayoun Najafizadeh, Iran (Islamic Republic of) |
| P11.38 |
Impact of two different TV content on promote organ donor registration Katayoun Najafizadeh, Iran (Islamic Republic of) |
| P11.40 |
Interstitial glucose metabolism monitoring is additional tool for objective assessment of a donor liver, prediction and immediate diagnosis of early graft dysfunction Alexander I Sushkov, Russian Federation |
| P11.41 |
Investigation of optimal temperature for machine perfusion of liver transplantation in donors after cardiac death Naruhito Takido, Japan |
| P11.42 (247.8 in Journal) |
Early Experience of 48-hour Normothermic Machine Perfusion in Human Kidneys Applying Urine Recirculation Annemarie Weissenbacher, Austria |
| P11.43 (244.2 in Journal) |
18-Year Follow-Up Of Kidney Donation In The Living Donor Transplant Program At A Reference Pediatric Hospital Mitzi R Becerra, Mexico |
| Poster Session: Pancreas and Islets |
| P12.02 |
Bionic pancreas – 3D bioprinting of a bionic organ with a vascular system – results of transplantation in large animals. Andrzej Berman, Poland |
| P12.02a (241.1 in Journal) |
Maturation and evaluation of 3D printed bionic pancreas with a dedicated bioreactor. Andrzej Berman, Poland |
| P12.03 |
Report of the first 70 pancreas transplant in a Latin-American Center Maria Florencia Fernandez, Argentina |
| P12.04 |
Switch from Calcineurin Inhibitor to Belatacept in kidney-pancreas transplant recipients. Single-center retrospective study from Argentina Sebastián Jaurretche Sr., Argentina |
| P12.05 |
Bionic Pancreas - the first results of functionality of 3D-bioprinted bionic tissue model transplantation with pancreatic islets Andrzej Berman, Poland |
| P12.06 |
Effect of supplementing taurine to the developed low-temperature islet preservation solution Jae-Kyung Park, Korea |
| P12.07 |
The role of pancreatic exocrine secretion in weight gain following pancreas transplantation Michael D Williams, United States |
| P12.08 (241.12 in the Journal) |
4-Octyl itaconate inhibits hypoxia-induced injuries on β-cell via reducing LDHA-mediated ROS generation Jianmin Wu, People's Republic of China |
| P12.11 |
Immunomodulatory Microporous Annealed Particle (MAP) gel protects delivery of islets to promote islet transplantation outcomes. Kenneth L. Brayman, United States |
| P12.12 |
The impact of recipient body mass index on outcomes of pancreas transplantation: A systematic review Harry J. de Souza, Australia |
| P12.13 |
Simultaneous kidney and pancreas transplantation in patients with type 1 diabetes mellitus, almenara hospital Lima-Peru, 2009-2021 Sherley Diestra Sr., Peru |
| P12.14 |
Liver surface can be a promising transplant site for pancreatic islets using a gelatin hydrogel nonwoven fabric Yukiko Endo, Japan |
| P12.15 |
Dapagliflozin for the treatment of Post-Transplant Diabetes Mellitus after Pancreas Transplantation: a case report with a 14-month follow-up Alessandro Mattina, Italy |
| P12.16 |
Availability of using amnion for islet transplantation Naoaki Sakata, Japan |
| P12.17 |
Simultaneous pancreas-kidney transplantation in one Russian transplant center Nikita Sergeevich Zhuravel, Russian Federation |
| P12.18 (343.6 in Journal) |
Outcomes of simultaneous kidney-pancreas transplantation in patients with type-1 and type-2 diabetes mellitus Hosein Shokouh-Amiri, United States |
| Poster Session: Pediatric Transplantation |
| P13.01 |
Pediatric liver transplantation for inborn errors of metabolism at the Hospital Juan P Garrahan, Argentina V. G Bindi, Argentina |
| P13.02 |
Significant fall in living donation rates of pediatric kidney transplants in Puerto Rico Nilka deJesus-Gonzalez, Puerto Rico |
| P13.03 |
Multidisciplinary Approach to Hepatoblastoma in Pediatric Liver Transplantation Angel Flores-Huidobro Martinez, United States |
| P13.04 |
Association between vitamin D deficiency and anemia in pediatric renal transplant recipients Esra Baskin, Turkey |
| P13.05 |
Probable posttransplant lymphoproliferative disorder after pediatric living donor liver transplantation: is a biopsy still needed? Muneyuki Matsumura, Japan |
| P13.06 |
Valve bladder diversion, making possible a kidney transplant Ramiro Perea, Argentina |
| P13.07 |
Detecting Subclinical Rejection using dd-cfDNA in Pediatric Kidney Transplant Auda M. V. Plaud Gonzalez, Puerto Rico |
| P13.08 |
Pediatric kidney transplantation in the Middle-East: challenges and solutions Bassam Saeed, Syrian Arab Republic |
| P13.09 |
Biliary atresia: intention-to-treat analysis in a pediatric liver transplant center Joao Seda Neto, Brazil |
| P13.10 |
Secondary ureteral re-implantation for persistent urinary leakage following renal transplantation in a Nigerian pediatric patient: A case report. Olalekan O. Olatise, Nigeria |
| P13.11 |
The largest single center report on hypertyrosinemia and liver transplantation Seyed Ali Malek Hosseini, Iran (Islamic Republic of) |
| P13.12 (243.12 in the Journal) |
A mixed-method systematic review examining the effects of digital behaviour change interventions (DBCIs) focussing on improving medication adherence in adolescent and young adult kidney transplant patients. Akanksha Singh, United Kingdom |
| P13.13 |
Pediatric Transplant and SARS Cov2 in a Country with high lethality. Luciola Vasquez, Peru |
| P13.14 |
Liver Transplantation in Alagille Syndrome with NOTCH2 genetic variant. Case Report Luciola Vasquez, Peru |
| P13.15 |
Experience in Pediatric Renal Transplantation. Guillermo Almenara Irigoyen National Hospital- Lima, Peru. 2009 - 2021 Luciola Vasquez, Peru |
| P13.16 |
Experience in a COVID19 nephrology center and pediatric kidney transplant Gabriela Gutiérrez Garcete, Paraguay |
| P13.17 |
Clinical features and outcomes following SARS-cov-2 infection in pediatric liver transplant patients Figen Ozcay, Turkey |
| P13.18 |
Our pediatric liver and kidney transplant activities in 2021 Emre Karakaya, Turkey |
| P13.19 |
Decrease incidence of typical hemolytic uremic syndrome as a cause for kidney transplantation in children at Garrahan hospital Natalia Panero, Argentina |
| Poster Session: Thoracic |
| P14.01 |
Cryobiopsy in the diagnosis of lung allograft rejection : Brazilian case series. Carlos E Belon, Brazil |
| P14.02 |
Viability of native kidney in cardiorenal transplantation Rosario Della Cella Figueredo, Argentina |
| P14.03 |
The usefulness of non-HLA monitoring during graft rejection surveillance in heart transplantation Olga L. Vanco, Argentina |
| P14.04 |
Lung transplant: supply or demand problem? Description of real donor patients in a Public Hospital of the Argentine Republic Daniel A Rodriguez Lic., Argentina |
| P14.05 |
Prone position: a measure of lung protection in potential lung donors. Case report Daniel A Rodriguez Lic., Argentina |
| P14.06 |
Lung procurement: Inclusion of modern variables to assess its quality. Descriptive study in a Public Hospital of the Argentine Republic Daniel A Rodriguez Lic., Argentina |
| P14.07 |
Use of grafts with extended ischemic time (above 4 hours or more): analysis of the experience of the largest Brazilian heart transplant center, from 2013 to 2022.
Ronaldo Honorato Barros Santos, Brazil |
| P14.08 |
Outcomes of heart failure patients excluded from heart transplant waiting list Maria Simonenko, Russian Federation |
| P14.09 |
Donor-derived cell free DNA is associated with antibody-mediated rejection and impaired cardiac hemodynamics in patients with heart transplantation Giosafat Spitaleri, Italy |
| P14.10 |
Heart transplant quilty lesions are associated with an immunologic tolerant profile Jose R Torrealba, United States |
| P14.11 |
Lung transplantation in adult patients with bronchiectasis
Esteban Wainstein, Argentina |
| P14.14 |
The experience of physical activities in lung transplant recipients：a qualitative study Wang Ruiting, Taiwan |
| P14.15 |
Early preventive “coronary sealing” of transmitted coronary artery disease with stent PTCA to improve outcomes of heart transplantation Alex O Shevchenko, Russian Federation |
| P14.16 |
Acute and chronic allograft rejection in the uruguayan lung transplant program in the 2003 – 2022 period Isabel Villanueva, Uruguay |
| Poster Session: Transplant Immunosuppression |
| P15.01 |
Posterior reversible encephalopathy syndrome in transplant patients: diagnosis and management Aydincan Akdur, Turkey |
| P15.02 (245.12 in the Journal) |
4-Octyl itaconate inhibits T cells’ proliferation and aerobic glycolysis to prevent immune over activation Yao Deng, People's Republic of China |
| P15.03 |
Granulocyte colony-stimulating factor with or without immunosuppression reduction in neutropenic kidney transplant recipients Shaifali Sandal, Canada |
| P15.04 |
Human Primary Renal Tubuloids as Tools for Calcineurin inhibitor Nephrotoxicity Assessment Puxun Tian, People's Republic of China |
| P15.05 |
Safety of once-weekly dulaglutide on post-transplant diabetes mellitus: a preliminary single-centre experience Alessandro Mattina, Italy |
| P15.06 |
Distinct FOXP3 gene expression in the peripheral blood and inside renal allografts is associated with use of mTOR inhibitors and extended criteria kidney donor
Mario Abbud-Filho Sr., Brazil |
| P15.07 |
Risk prediction model for immunosuppressive medication nonadherence in kidney transplantation recipients Lei Dong, People's Republic of China |
| P15.08 |
Effects of bcl-6 inhibition on the humoral alloresponse Rens Kraaijeveld, Netherlands |
| P15.09 |
Determination of tacrolimus dosage using machine learning in kidney transplantation Sangkyun Mok, Korea |
| P15.10 |
The impact of different induction immunosuppression protocol on patient survival, graft survival and acute graft rejection after kidney transplantation – multicenter study Matej Vnučák, Slovakia (Slovak Republic) |
| Poster Session: Transplant Infectious Diseases and Covid-19 |
| P16.01 |
Decreased mortality from SARS-coV-2 infection in kidney transplant recipients over the course of the pandemic Enver Akalin, United States |
| P16.02 |
Safety and effectiveness of Covid-19 vaccination in the islet transplant recipients Mateusz Ogledzinski, United States |
| P16.03 |
Argentine COVID 19 Registry transplantation: A national cohort study Liliana Bisigniano MD, Argentina |
| P16.04 |
Seroprevalence of SARS-CoV-2 antibodies following vaccination amongst renal transplant recipients: A single centre-experience John Black, United Kingdom |
| P16.06 |
Seroconversion in pacients after SARS-cov-2 ChAdOx1 nCoV-19/AZD1222 vaccination in hemodialysis patients and kidney transplant recipients Alfredo Chew-Wong, Mexico |
| P16.07 |
Association Between SARS-CoV-2 Infection and De Novo HLA Donor Specific Antibody Production in Lung Transplant Recipients: Single-center study Mohamed Elrefaei, United States |
| P16.08 |
Covid-19 positive kidney transplant recipients behave differently compared to non-transplant patients ICU: single center experience Osama Ashry Gheith, Egypt |
| P16.09 |
Spectrum of side effects of mRNA COVID-19 vaccine among Asian kidney transplant recipients and healthcare providers at the Singapore General Hospital Terence Kee, Singapore |
| P16.10 |
SARS-CoV-2 vaccination in liver transplant recipients Daniela Kniepeiss, Austria |
| P16.11 |
Decreased immunogenicity after SARS-CoV-2 vaccination in liver and kidney transplant recipients Jae Hyun Kwon, Korea |
| P16.12 |
Mortality in patients on dialyses and kidney transplant recipients during pandemic Jolanta Malyszko, Poland |
| P16.13 |
Covid-19 infection in kidney transplant recipients from the IPS: evolution of kidney function and complications Adriana Carolina C Martínez Cortti Sr., Paraguay |
| P16.14 |
Impact of vaccination against Covid 19 in the population of intrathoracic transplant recipients during the pandemic Ludmila Morcos, Argentina |
| P16.15 |
HLA genetic frequency in Renal Transplantation Patients, dead by covid-19 Gustavo Piccinelli, Argentina |
| P16.17 |
Analyzing the impact of the COVID-19 pandemic on communication and education strategies across transplant programs in Canada Shaifali Sandal, Canada |
| P16.18 |
Behavior of anti- SARS-CoV-2 antibodies in renal transplant patients vaccinated prior to transplantation Ruben O. Schiavelli, Argentina |
| P16.19 |
Omicron COVID-19 in Kidney Transplant Recipients Gisela Serra Rodrigues Costa, Brazil |
| P16.21 |
Impact of vaccination against SARS CoV2 in kidney transplant recipients Marcelo F Taylor, Argentina |
| P16.23 |
Antibody response to SARS-CoV-2 mRNA vaccine in kidney transplant recipients
Ali B. Mahgoub, Qatar |
| P16.25 |
Immunoglobulin M (IgM) delays disease in K18-hACE2 mice infected with SARS-CoV-2 Kenneth L. Brayman, United States |
| P16.26 |
Adenosine A2A receptor (A2AR) agonists improve survival in K28-hACE2 mice and Syrian hamsters following SARS CoV-2 infection Kenneth L. Brayman, United States |
| P16.27 |
A Case of Cytomegalovirus (CMV) Esophagitis Without CMV Viremia After SARS-CoV-2 Infection In A Kidney Transplant Recipient While on CMV Prophylaxis Walaa Dabbas, United States |
| P16.29 |
Clinical profile and outcomes of COVID 19 among renal transplant recipients across three waves of SARS CoV2 infection: A multicenter study from South India Jeethu Joseph Eapen, India |
| P16.31 |
COVID-19 infection in kidney transplant patients in a Colombian cohort Jessica JL Pinto Ramirez PR, Colombia |
| P16.32 |
COVID-19 clinical outcomes, coinfection and secondary infections in solid organ transplant recipients Tugba Yanik Yalcin, Turkey |
| P16.33 |
Comparison of kidney transplant outcomes before and after Coronavirus Disease 2019 pandemic : a single-institution experience Yang-Wook Kim, Korea |
| P16.34 |
Native kidney infection due to non-tuberculous mycobacteria diagnosed by molecular multiplex test in renal transplant: a case report Lucila Martin Rollan, Argentina |
| P16.35 |
Pandemic research in organ transplantation from India Hari Shankar Meshram, India |
| P16.36 |
Effectiveness of SARS-cov 2 vaccination in kidney transplant patients in Chile
Jaqueline Pefaur Penna, Chile |
| P16.37 |
Outcomes of COVID-19 vaccination among Kidney Transplant Recipients admitted for COVID-19 at the National Kidney and Transplant Institute: A Retrospective Study Fern Lyse Q. Peñaranda, Philippines |
| P16.39 |
Immunogenicity of the inactivated SARS-CoV-2 vaccine (BBIBP-CorV; Sinopharm) and short term clinical outcomes in vaccinated solid organ transplant recipients: a prospective cohort study Mojtaba Shafiekhani, Iran (Islamic Republic of) |
| P16.40 |
Physicians’ opinions regarding low-level Epstein-Barr virus DNA levels from PCR testing Akos Somoskovi, United States |
| P16.41 |
Acute kidney rejection after anti-sars-cov-2 virus-vectored vaccine – case report Matej Vnučák, Slovakia (Slovak Republic) |
| P16.42 (248.12 in the Journal) |
Critically important outcomes for infection in trials in kidney transplantation: an international survey of patients, caregivers and health professionals Samuel Chan, Australia |
| Poster Session: Xenotransplantation / Cell and Tissue Banking |
| P17.01 |
Bioink based on the dECM for 3D-bioprinting of bionic tissue - first results obtained on murine model Andrzej Berman, Poland |
| P17.02 |
Towards bionic organs: biocompatibility of newly developed porcine dECM-based hydrogels Andrzej Berman, Poland |
| P17.03 |
Quadruple KO porcine adult pancreatic islet induced long-term xenograft survival in diabetic mice Kyungmin Kwak, Korea |
| P17.04 |
Feasibility and safety of intravenous infusion of autologous Umbilical Cord Blood for newborns with perinatal Hypoxic-Ischemic Encephalopathy: Argentina´s experience
Cecilia Gamba, Argentina |
| P17.05 |
Comparison of laboratory- and clinical-grade reagents in isolation and cultivation of human amniotic epithelial cells Chika Takano, Japan |
| P17.06 |
Escape from macrophage-mediated rejection by human surfactant protein (SP) -A Chiyoshi Toyama, Japan |
| P17.08 |
Study of umbilical mesenchymal stem cells derived exosomes in enhancing UCB-Treg immune-suppressive function after adoptive transfer in X-GVHD model mice Juan Zhang, People's Republic of China |
| P17.09 |
CD27-expressing xenoantigen-expanded human regulatory T cells are efficient in suppressing xenogeneic immune response Lu Cao, People's Republic of China |
| P17.10 |
Effect of factor H on complement alternative pathway activation in human serum remains on porcine cells lacking N-glycolylneuraminic acid Hee Jung Kang, Korea |
